Londt R, Semple L, Esmail A, Pooran A, Meldau R, Davids M
Microorganisms. 2025; 13(2).
PMID: 40005712
PMC: 11857998.
DOI: 10.3390/microorganisms13020345.
Sardar P, Beresford-Jones B, Xia W, Shabana O, Suyama S, Ramos R
Nat Microbiol. 2025; 10(3):795-807.
PMID: 39929976
PMC: 11879847.
DOI: 10.1038/s41564-025-01930-y.
Zuquete S, Ferreira M, Delgado I, Gazalle P, Andaluz S, Rosa M
iScience. 2025; 27(12):111232.
PMID: 39759015
PMC: 11700634.
DOI: 10.1016/j.isci.2024.111232.
Hinz A, Stankiewicz S, Litewka J, Ferdek P, Sochalska M, Bzowska M
Int J Nanomedicine. 2024; 19:13165-13181.
PMID: 39670198
PMC: 11635164.
DOI: 10.2147/IJN.S479710.
Seidler Y, Rimbach G, Luersen K, Vinderola G, Ipharraguerre I
Front Microbiol. 2024; 15:1452725.
PMID: 39507340
PMC: 11538067.
DOI: 10.3389/fmicb.2024.1452725.
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.
Agrez M, Chandler C, Thurecht K, Fletcher N, Liu F, Subramaniam G
Sci Rep. 2024; 14(1):26737.
PMID: 39501043
PMC: 11538426.
DOI: 10.1038/s41598-024-78150-7.
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade.
Rwandamuriye F, Wang T, Zhang H, Elaskalani O, Kuster J, Ye X
Oncoimmunology. 2024; 13(1):2395067.
PMID: 39188754
PMC: 11346538.
DOI: 10.1080/2162402X.2024.2395067.
Nano-Pulse Stimulation Treatment Inhibits Pan02 Murine Pancreatic Tumor Growth and Induces a Long-Term Adaptive Immune Response with Abscopal Effects When Combined with Immune-Enhancing Agents.
McDaniel A, Rothstein K, Gonzalez D, Nuccitelli R
Bioelectricity. 2024; 6(2):108-117.
PMID: 39119566
PMC: 11304879.
DOI: 10.1089/bioe.2024.0011.
Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses.
Ou B, Baillet J, Filsinger Interrante M, Adamska J, Zhou X, Saouaf O
Sci Adv. 2024; 10(32):eadn7187.
PMID: 39110802
PMC: 11305391.
DOI: 10.1126/sciadv.adn7187.
An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation.
Alakhras N, Zhang W, Barros N, Sharma A, Ropa J, Priya R
Proc Natl Acad Sci U S A. 2024; 121(32):e2400153121.
PMID: 39088391
PMC: 11317592.
DOI: 10.1073/pnas.2400153121.
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.
Soni D, Borriello F, Scott D, Feru F, DeLeon M, Brightman S
Sci Adv. 2024; 10(27):eadg3747.
PMID: 38959314
PMC: 11221515.
DOI: 10.1126/sciadv.adg3747.
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.
Aljabali A, Obeid M, Gammoh O, El-Tanani M, Mishra V, Mishra Y
Cancers (Basel). 2024; 16(11).
PMID: 38893150
PMC: 11171400.
DOI: 10.3390/cancers16112030.
Cancer mRNA vaccines: clinical advances and future opportunities.
Sayour E, Boczkowski D, Mitchell D, Nair S
Nat Rev Clin Oncol. 2024; 21(7):489-500.
PMID: 38760500
DOI: 10.1038/s41571-024-00902-1.
High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists.
Gilmour B, Corthay A, Oynebraten I
NPJ Vaccines. 2024; 9(1):83.
PMID: 38702320
PMC: 11068792.
DOI: 10.1038/s41541-024-00869-1.
Testing GMMA with and without Aluminium Salt-Based Adjuvants in Animal Models.
Mancini F, Caradonna V, Alfini R, Aruta M, Vitali C, Gasperini G
Pharmaceutics. 2024; 16(4).
PMID: 38675229
PMC: 11054012.
DOI: 10.3390/pharmaceutics16040568.
The effect of probiotic Bl-04 on innate antiviral responses .
Latvala S, Lehtinen M, Makela S, Nedveck D, Zabel B, Ahonen I
Heliyon. 2024; 10(8):e29588.
PMID: 38665561
PMC: 11043947.
DOI: 10.1016/j.heliyon.2024.e29588.
Poly(I:C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen(s).
Tandel N, Patel D, Thakkar M, Shah J, Tyagi R, Dalai S
Heliyon. 2024; 10(5):e26887.
PMID: 38455541
PMC: 10918150.
DOI: 10.1016/j.heliyon.2024.e26887.
Microbiota in cancer: molecular mechanisms and therapeutic interventions.
Chen Z, Guan D, Wang Z, Li X, Dong S, Huang J
MedComm (2020). 2023; 4(6):e417.
PMID: 37937304
PMC: 10626288.
DOI: 10.1002/mco2.417.
Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis.
Kang C, Li X, Liu P, Liu Y, Niu Y, Zeng X
Front Immunol. 2023; 14:1276512.
PMID: 37915574
PMC: 10616250.
DOI: 10.3389/fimmu.2023.1276512.
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
Do K, Willenzon S, Ristenpart J, Janssen A, Volz A, Sutter G
Front Cell Infect Microbiol. 2023; 13:1259822.
PMID: 37854858
PMC: 10580083.
DOI: 10.3389/fcimb.2023.1259822.